Allogene Therapeutics Inc. (ALLO)
NASDAQ · Healthcare
Allogene Therapeutics Inc. Net Income 2019–2025
Allogene Therapeutics Inc. annual/quarterly net income history and growth rate from 2019 to 2025. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Allogene Therapeutics Inc. net income for the quarter ending September 30, 2025 was -41.4 M, a 37.55% decrease year-over-year.
- Allogene Therapeutics Inc. net income for the twelve months ending September 30, 2025 was -218.4 M, a 19.98% decrease year-over-year.
- Allogene Therapeutics Inc. annual net income for 2025 was -190.9 M, a 25.90% decrease from 2024.
- Allogene Therapeutics Inc. annual net income for 2024 was -257.6 M, a 21.29% decrease from 2023.
- Allogene Therapeutics Inc. annual net income for 2023 was -327.3 M, a 3.86% decrease from 2022.
- Allogene Therapeutics Inc. annual net income for 2022 was -340.4 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Allogene Therapeutics Inc. Net Income — FAQ
Allogene Therapeutics Inc. (ALLO) net income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Allogene Therapeutics Inc.'s net income?
Allogene Therapeutics Inc. (ALLO) reported net income of -$191M for fiscal 2025.
Where can I see ALLO's net income history?
The chart and table above show Allogene Therapeutics Inc.'s net income by year and by quarter, including the growth rate.